Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New class of toluidine sulfonamides set to enter clinical testing for the treatment of MM

Dec. 23, 2010

Phase III trial of INC-424 in myelofibrosis meets primary endpoint

Dec. 22, 2010

Cyclacel reports topline data from phase IIb APPRAISE trial of seliciclib

Dec. 22, 2010

Abbott divulges new inhibitors of IGF-I receptor

Dec. 22, 2010

LY-2784544 inhibits V617F-mutant JAK-2 signaling and advances through clinical development

Dec. 22, 2010

Nerviano Medical Sciences describes new inhibitors of PARP-1

Dec. 22, 2010

Exelixis patents novel PI3K-alpha/mTORC1 inhibitors

Dec. 22, 2010

Tasigna approved in Japan for newly diagnosed Ph+ CML

Dec. 21, 2010

New inhibitors of Aurora kinase A and B presented

Dec. 21, 2010

New inhibitors CK II and/or pim-1 discovered at Cylene Pharma

Dec. 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...